Related Experiment Video
Updated: Jul 2, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Barriers to optimal hypertension control
1Department of Medicine ,Columbia University, New York, NY 10032, USA. goo1@columbia.edu
Insights
Bridging the gap in hypertension control requires addressing patient adherence and physician clinical inertia. Overcoming these barriers is crucial for effective blood pressure management and patient outcomes.
Area of Science:
- Cardiology
- Public Health
- Health Services Research
Background:
- A significant gap exists in translating clinical trial evidence into practice for optimal hypertension management.
- Barriers to blood pressure (BP) control are categorized into patient-related, physician-related, and healthcare system factors.
Purpose of the Study:
- To identify and analyze the primary barriers hindering effective hypertension control in clinical practice.
- To highlight the critical role of medication adherence and physician clinical inertia.
Main Methods:
- Review of existing literature and clinical guidelines on hypertension management.
- Categorization and analysis of identified barriers to blood pressure control.
Main Results:
- Patient-related barriers include poor medication adherence, beliefs, depression, health literacy, comorbidity, and motivation.
- Physician-related barriers are dominated by clinical inertia, defined as failure to initiate or intensify therapy for uncontrolled BP.
- Reasons for clinical inertia include overestimation of care provided, lack of training, and avoidance of treatment intensification.
Conclusions:
- Improving hypertension control necessitates addressing patient adherence and physician clinical inertia.
- Strategies must target patient-specific issues and physician behaviors to enhance treatment intensification and achieve target BP levels.
Abstract:
There is an obvious gap in the translation of clinical trial evidence into practice with regards to optimal hypertension control. The three major categories of barriers to BP control are patient-related, physician-related, and medical environment/health care system factors. Patient-related barriers include poor medication adherence, beliefs about hypertension and its treatment, depression, health literacy, comorbidity, and patient motivation. The most pertinent is medication adherence, given its centrality to the other factors. The most salient physician-related barrier is clinical inertia--defined, as the failure of health care providers to initiate or intensify drug therapy in a patient with uncontrolled BP. The major reasons for clinical inertia are: 1) overestimation of the amount of care that physicians provide; 2) lack of training on how to attain target BP levels; and 3) clinicians' use of soft reasons to avoid treatment intensification by adopting a "wait until next visit" approach in response to patients' excuses.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Hypertension IV: Drug Therapy and Lifestyle Modifications
Errors occurring during blood pressure monitoring
Several factors...
Hypertension I: Introduction
Hypertension V: Nursing Management
Hypertension III: Clinical Manifestations and Diagnostic Studies